EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Management of PALB2 ‐associated breast cancer: A literature review and case report

Angela Toss, Ornella Ponzoni, Beatrice Riccò iD, Claudia Piombino, Luca Moscetti, Francesca Combi, Enza Palma, Simona Papi, Elena Tenedini, Giovanni Tazzioli iD, Massimo Dominici, Laura Cortesi

Clinical Case Reports · 2023-08 · 11 (8)

DOI: 10.1002/ccr3.7747 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 22.08.2023. Verfasst von Angela Toss und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Hematology Azienda Ospedaliero-Universitaria di Modena Modena Italy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Clinical Message Germline pathogenic variants (PV) of the PALB2 tumor suppressor gene are associated with an increased risk of breast, pancreatic, and ovarian cancer. In previous research, PALB2 ‐associated breast cancer showed aggressive clinicopathological phenotypes, particularly triple‐negative subtype, and higher mortality regardless of tumor stage, type of chemotherapy nor hormone receptor status. The identification of this germline alteration may have an impact on clinical management of breast cancer (BC) from the surgical approach to the systemic treatment choice. We herein report the case of a patient with a germline PV of PALB2 , diagnosed with locally advanced PD‐L1 positive triple‐negative BC, who progressed after an immune checkpoint inhibitor (ICI)‐containing regimen and then experienced a pathologic complete response after platinum‐based chemotherapy. This case report hints a major role of the germline PALB2 alteration compared to the PD‐L1 expression as cancer driver and gives us the opportunity to extensively review and discuss the available literature on the optimal management of PALB2 ‐associated BC. Overall, our case report and review of the literature provide additional evidence that the germline analysis of PALB2 gene should be included in routine genetic testing for predictive purposes and to refine treatment algorithms.

Schlagwörter

Stichwörter der Autor:innen

PALB2PARP inhibitorbreast cancerimmunotherapy

Autor:innen und Institutionen

  • Department of Oncology and Hematology Azienda Ospedaliero-Universitaria di Modena Modena Italy.
  • Department of Medical and Surgical Sciences University of Modena and Reggio Emilia Modena Italy.
  • Unit of Breast Surgical Oncology Azienda Ospedaliero-Universitaria di Modena Modena Italy.
  • Department of Biomedical, Metabolic and Neural Sciences, International Doctorate School in Clinical and Experimental Medicine University of Modena and Reggio Emilia Modena Italy.
  • Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics Unit Azienda Ospedaliero-Universitaria di Modena Modena Italy.

ORCID-Profile: Beatrice Riccò, Giovanni Tazzioli

Zitieren

APA

Toss, A., Ponzoni, O., Riccò, B., Piombino, C., Moscetti, L., Combi, F., Palma, E., Papi, S., Tenedini, E., Tazzioli, G., Dominici, M., & Cortesi, L. (2023). Management of PALB2 ‐associated breast cancer: A literature review and case report. Clinical Case Reports, 11(8). https://doi.org/10.1002/ccr3.7747

Vancouver

Toss A, Ponzoni O, Riccò B, Piombino C, Moscetti L, Combi F, et al. Management of PALB2 ‐associated breast cancer: A literature review and case report. Clinical Case Reports. 2023;11(8). doi:10.1002/ccr3.7747

BibTeX
@article{Toss2023,
  author = {Toss, Angela and Ponzoni, Ornella and Riccò, Beatrice and Piombino, Claudia and Moscetti, Luca and Combi, Francesca and Palma, Enza and Papi, Simona and Tenedini, Elena and Tazzioli, Giovanni and Dominici, Massimo and Cortesi, Laura},
  title = {Management of PALB2 ‐associated breast cancer: A literature review and case report},
  journal = {Clinical Case Reports},
  year = {2023},
  volume = {11},
  number = {8},
  doi = {10.1002/ccr3.7747}
}
Kostenlos starten →